Press Releases

United BioSource Corporation (UBC) today announced the acquisition of Abt Bio-Pharma Solutions, Inc. (ABS), a Boston, Massachusetts-based provider of health economics and outcomes research, registries and observational studies, and market access solutions to the biopharmaceutical, medical device, and diagnostics industries.

The acquisition of ABS is part of UBC’s ongoing strategy to build a “best in class” portfolio of scientific and medical affairs solutions to support biopharmaceutical and medical technology companies. With this acquisition UBC further expands its industry-leading team of senior experts in comparative effectiveness and comparative value; increases its registry and observational study practices; and reinforces its commercial strategy and market access capabilities. The addition of ABS scientists and resources establishes UBC with the largest presence and operational reach in the New England biomedical corridor.

“The scientists and capabilities that we gain with ABS are an excellent fit with our strategy,” said Ethan Leder, CEO of United BioSource Corporation. “We have the industry’s leading roster of scientists to address product value and guide the safe and effective use of biomedical technologies. Whether we are building scientific evidence to address product value and comparative effectiveness or leveraging our expertise and technology to manage the safety risks associated with a new medicine, UBC plays a pivotal role in the development and commercialization of our clients’ products.”

Abt Associates President and Chief Executive Officer Kathleen Flanagan stated, “After building ABS into a respected player in its field, we are gratified to see our colleagues join a company that shares our values and can realize even greater potential. At UBC, there will be new resources and increased reach that translates into new opportunities for our clients to support their products.”

About United BioSource Corporation
United BioSource Corporation (UBC) is a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies. We help deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle. The company is headquartered in Bethesda, Maryland, with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.

About Abt Bio-Pharma Solutions
Abt Bio-Pharma Solutions (ABS) is a pharmaceutical and medical device services organization combining capabilities in biostatistics, data management, epidemiology, clinical trials management, pricing reimbursement and research services to help companies demonstrate product value in a competitive global marketplace. For more information visit www.abtbiopharma.com.

About Abt Associates
Abt Associates applies research, program implementation and technical assistance, and policy expertise to a wide range of social, economic and health policy issues; international development; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,500 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East. For more information, visit www.abtassociates.com.